• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-D)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-D) Back to Search Results
Model Number G146
Device Problems Signal Artifact/Noise (1036); Over-Sensing (1438); Pacing Problem (1439)
Patient Problem Asystole (4442)
Event Date 07/21/2022
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded a more than 2 seconds pause with pacing inhibition and over sensed noisy signals on all channels.Impedance values were stable in the year view.Similar noise without inhibition was observed at other atrial tachy response episode.Various procedures were recommended to determine the origin of the observed behavior.The field representative was able to recreate the noise when the patient moves arm across his chest, but no noise was observed on the lv lead.A chest x ray was recommended.The crt-d remains in service.No additional adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that this system with a cardiac resynchronization therapy defibrillator (crt-d), right ventricular (rv) and right atrial (ra) leads recorded a more than 2 seconds pause with pacing inhibition and over sensed noisy signals on all channels.Impedance values were stable in the year view.Similar noise without inhibition was observed at other atrial tachy response episode.Various procedures were recommended to determine the origin of the observed behavior.The field representative was able to recreate the noise when the patient moves arm across his chest, but no noise was observed on the lv lead.A chest x ray was recommended.Following the troubleshooting that was done in-clinic with the assistance of tech support, it was decided that the patient would need an extraction of the affected leads.Patient was discharged with programming changes that would decrease the risk of pacing inhibition.Patient and staff were to coordinate.The field representative has not received any further information on the patient.The crt-d, rv and ra leads have been explanted at this time.No additional adverse patient effects were reported.
 
Event Description
It was reported that this system with a cardiac resynchronization therapy defibrillator (crt-d), right ventricular (rv) and right atrial (ra) leads recorded a more than 2 seconds pause with pacing inhibition and over sensed noisy signals on all channels.Impedance values were stable in the year view.Similar noise without inhibition was observed at other atrial tachy response episode.Various procedures were recommended to determine the origin of the observed behavior.The field representative was able to recreate the noise when the patient moves arm across his chest, but no noise was observed on the lv lead.A chest x ray was recommended.Following the troubleshooting that was done in-clinic with the assistance of tech support, it was decided that the patient would need an extraction of the affected leads.Patient was discharged with programming changes that would decrease the risk of pacing inhibition.Patient and staff were to coordinate.The field representative has not received any further information on the patient.The crt-d, rv and ra leads have been explanted at this time.The crt-d has been returned for analysis.No additional adverse patient effects were reported.
 
Manufacturer Narrative
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.Dimensional analysis of the header was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the pacing, and sensing functions were tested.Impedance testing was completed, and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN X4 CRT-D
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-D)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16910072
MDR Text Key314978506
Report Number2124215-2023-23259
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534577
UDI-Public00802526534577
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 11/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/29/2017
Device Model NumberG146
Device Catalogue NumberG146
Device Lot Number371456
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/20/2023
Initial Date FDA Received05/11/2023
Supplement Dates Manufacturer Received08/08/2023
10/30/2023
Supplement Dates FDA Received08/16/2023
11/01/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/29/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age59 YR
Patient SexMale
-
-